bioRxivBiophysics
Revealing druggable cryptic pockets in the Nsp-1 of SARS-CoV-2 and other β-coronaviruses by simulations and crystallography
A. Borsatto, O. Akkad, I. Galdadas, S. Ma, S. Damfo, S. Haider, F. Kozielski, C. Estarellas, F. L. Gervasio
Abstract
Non-structural protein 1 (Nsp1) is a main pathogenicity factor of - and {beta}-coronaviruses. Nsp1 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suppresses the host gene expression by sterically blocking 40S host ribosomal subunits and promoting host mRNA degradation. This mechanism leads to the downregulation of the translation-mediated innate immune response in host cells, ultimately mediating the observed immune evasion capabilities of SARS-CoV-2. Here, by combining extensive Molecular Dynamics simulations, fragment screening and crystallography, we reveal druggable pockets in Nsp1. Structural and computational solvent mapping analyses indicate the partial crypticity of these newly discovered and druggable binding sites. The results of fragment-based screening via X-ray crystallography confirm the druggability of the major pocket of Nsp1. Finally, we show how the targeting of this pocket could disrupt the Nsp1-mRNA complex and open a novel avenue to design new inhibitors for other Nsp1s present in homologous {beta}-coronaviruses.
- organism: virus
- assay: structural biology
- research focus: drug response / drug discovery
- approach: deep learning
- approach: statistical model
- approach: simulation
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
Matthias Thoms, Robert Buschauer, … Roland Beckmann·SciencePeer-reviewed·Jul 17, 2020
- Two ligand-binding sites on SARS-CoV-2 non-structural protein 1 revealed by fragment-based x-ray screening
S. Ma, S. Damfo, … F. G. Kozielski·bioRxiv·Jun 12, 2022
- Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
T. Hussain, M. Afsar, … S. Tripathi·bioRxiv·Nov 2, 2021
- An evolutionarily conserved strategy for ribosome binding and inhibition by β-coronavirus non-structural protein 1
S. F. Maurina, J. P. O'Sullivan, … A.-L. Steckelberg·bioRxiv·Jun 7, 2023
- Structure of nonstructural protein 1 from SARS-CoV-2.
L. K. Clark, T. J. Green, C. M. Petit·bioRxiv·Nov 3, 2020
- SARS-CoV-2 Nsp1 binds ribosomal mRNA channel to inhibit translation
Katharina Noel Schubert, Evangelos D. Karousis, … Nenad Ban·Nature Structural & Molecular BiologyPeer-reviewed·Sep 9, 2020